Benzinga | Aug 11, 2020 05:43AM EDT

Credit Suisse Initiates Coverage On ALX Oncology Holdings with Outperform Rating, Announces Price Target of $53

Credit Suisse analyst Martin Auster initiates coverage on ALX Oncology Holdings (NASDAQ:ALXO) with a Outperform rating and announces Price Target of $53.